Determination of risk factors for cataract by aldose reductase genotype
OwnerShao Lee, Maggie Ng +4inventors
InventorsShao Lee, Maggie Ng, Juliana Chan, Julian Critchley, Christina West, Clive Cockram
Life of this patent
Estimating the term…
Loading patent…
OwnerShao Lee, Maggie Ng +4inventors
InventorsShao Lee, Maggie Ng, Juliana Chan, Julian Critchley, Christina West, Clive Cockram
Estimating the term…
This invention relates to methods for determining the risk of developing cataract in mammals, and, more specifically, in mammals, including humans, with non-insulin dependent diabetes. The methods are performed by determining the presence or absence of genetic markers in genomic DNA. The presence of a Z-2 allele, a microsatellite marker of the aldose reductase, is indicative of an increased risk for developing cataract. The presence of Z-4, a microsatellite allele of the aldose reductase gene, indicates a decreased risk for developing cataract. The methods comprise nucleic acid probes that hybridize to a nucleic acid encoding the microsatellite region of the mammalian aldose reductase gene. The probes may also be immobilized on a solid support to form a microarray. In addition, this invention is directed to methods for treating a mammal with a genetic predisposition for developing cataract; following a screening method that detects a Z-2 microsatellite marker of an aldose reductase gene the mammal is treated with an inhibitor of aldose reductase.
A method for determining risk of developing cataract in a mammal, said method comprising the step of:
A method for detecting increased risk of developing cataract in an individual of Chinese descent having non-insulin dependent diabetes, said method comprising:
A method for detecting increased risk of developing cataract in an individual of Chinese descent having non-insulin dependent diabetes, said method comprising:
A method for detecting decreased risk of developing cataract in an individual of Chinese descent having non-insulin dependent diabetes, said method comprising:
A method for detecting decreased risk of developing cataract in an individual of Chinese descent having non-insulin dependent diabetes, said method comprising:
A method for treating a mammal in need thereof having an increased risk of developing cataract as a result of presence of a Z-2 allele or absence of a Z-4 allele of aldose reductase, said method comprising:
A primer pair, wherein a first member of said pair comprises SEQ ID NO:
A polynucleotide primer for amplification of a microsatellite marker of an aldose reductase gene, said primers comprising SEQ ID NO:
A nucleic acid probe wherein said probe comprises a nucleotide sequence of at least 10 nucleotide bases that hybridize to a nucleic acid encoding a microsatellite marker of an aldose reductase gene.
An oligonucleotide probe comprising:
An array of nucleotide probes comprising:
Dependencies are inferred from the claim text.